| Literature DB >> 889418 |
C Swett, J O Cole, S Shapiro, D Slone.
Abstract
The frequency of extrapyramidal symptoms (EPS) attributed to chlorpromazine among 86 patients who received benztropine for the prevention of EPS (9.3%) was similar to that of the 568 patients who received chlorpromazine alone (10.6%). The data in this small sample indicated that the prophylactic use of benztropine had no effect in reducing the rate of EPS.Entities:
Mesh：
Substances：
Year: 1977 PMID： 889418 DOI： 10.1001/archpsyc.1977.01770200080009
Source DB: PubMed Journal: Arch Gen Psychiatry ISSN： 0003-990X